Organisation paid for research Program year 2025 Source: CMS Open Payments

Brany

Neither a doctor nor a teaching hospital

Research payments

$338,554

66 payments

Through program year 2025, Brany is reported as receiving $338,554 in research payments, across 66 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2025	Research	$195,018	37
2024	Research	$122,353	20
2019	Research	$21,183	9

Breakdown

Who paid Research payments · program years 2019–2025

Mannkind Corporation $170,128 24 payments
Organogenesis Inc. $99,533 22 payments
Karyopharm Therapeutics Inc. $47,710 11 payments
Spectrum Pharmaceuticals Inc. $21,183 9 payments

Studies the money was for Research payments · program years 2019–2025

Icon-1 Phase 3 Study of the Efficacy and Safety of Treatment With Mnkd-101, Clofazamine Inhalation Suspension $170,128 24 payments
20 VLU 003 AFF study $99,533 22 payments
A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma $47,710 11 payments
Spi-Poz-202 $20,388 8 payments
Spi-Poz-201 $795 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.